Skip to content

IBEX Limited IBEX Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

Genpact logo
GenpactG
ExlService Holdings logo
ExlService HoldingsEXLS
Calix logo
CalixCALX
Equinix, Inc. logo
Equinix, Inc.EQIX
Coastal Financial logo
Coastal FinancialCCB
IQVIA logo
IQVIAIQV

Other financials

Income statement

See full
Revenue$164.4M+16.8%
Gross profit$48.8M+9.1%
Operating income$16.2M+21.2%
Net income$13.3M+27.3%
EPS (diluted)$0.89+21.9%

Balance sheet

See full
Cash & equivalents$15.4M+18.7%
Total debt$63.2M-44.1%
Total equity$160.8M+29.5%
Total assets$297.2M+8.2%

Cash flow

See full
Operating cash flow$11.9M+34.4%
CapEx$5.3M+0.1%
Free cash flow$6.6M+85.1%

Valuation

See full
Market cap$389.76M+6.1%
Enterprise value$437.58M-6.4%
P/E8.3×-1.6×
P/S0.6×-0.1×

Profitability

See full
Gross margin29.9%-1.0pp
Operating margin9.2%+0.3pp
Net margin7.5%+0.6pp
FCF margin5.3%+2.8pp

Returns & leverage

See full
Return on equity33.1%+6.9pp
Debt / equity0.4×-0.5×
Current ratio+0.3×

Where this comes from

Reported directly by IBEX Limited in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: IBEX Limited’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about IBEX Limited's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is IBEX Limited's common stock, shares authorized (in shares)?
IBEX Limited (IBEX) reported common stock, shares authorized (in shares) of $108.06M in Q1 2026.
How has IBEX Limited's common stock, shares authorized (in shares) changed year-over-year?
IBEX Limited's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $108.06M to $108.06M.
What is the long-term trend for IBEX Limited's common stock, shares authorized (in shares)?
Over 2 years (2023 to 2025), IBEX Limited's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $108.06M to $108.06M.